Intercept Pharmaceuticals, Inc. – Trademark Portfolio

Entity Type: 03

Intercept Pharmaceuticals, Inc. holds 64 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 36 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 7 Nice Classification classes. Currently, 14 trademarks are registered. Notable registered marks include OCALIVA, INTERCEPT, PBC LIVING, RETHINKPBC, and RETHINK PBC. The owner is based in New York, NY.